HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anterior lumbosacral radiculopathy after intrathecal methotrexate treatment.

Abstract
Intrathecal chemotherapy with methotrexate or cytosine arabinoside is the standard approach to prophylaxis and treatment of central nervous system leukemia in children. Progressive paraplegia, one of the devastating neurologic complications related to this mode of treatment, has been attributed to spinal cord toxicity. Reported are three children who developed progressive paraparesis after intrathecal methotrexate administration followed by complete or partial recovery. Gadolinium enhancement of anterior lumbosacral spinal nerve roots was demonstrated in all three patients, and an elevation of cerebrospinal fluid immunoglobulin G synthesis was evident in two patients with more severe symptoms. The clinical data suggest that anterior lumbosacral radiculopathy is also a type of neurologic complication associated with intrathecal methotrexate treatment.
AuthorsS Koh, M D Nelson Jr, A Kovanlikaya, L S Chen
JournalPediatric neurology (Pediatr Neurol) Vol. 21 Issue 2 Pg. 576-8 (Aug 1999) ISSN: 0887-8994 [Print] United States
PMID10465148 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antimetabolites, Antineoplastic
  • Methotrexate
Topics
  • Antimetabolites, Antineoplastic (adverse effects)
  • Cerebrospinal Fluid (cytology, immunology)
  • Child, Preschool
  • Humans
  • Injections, Spinal
  • Magnetic Resonance Imaging
  • Male
  • Methotrexate (adverse effects)
  • Paresis (etiology)
  • Peripheral Nervous System Diseases (etiology)
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (drug therapy)
  • Spinal Nerve Roots (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: